All our
news

Discuss, meet & share

Press releases

Intrasense launches its AI Hub in partnership with Milvue

17 May 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, announces, in partnership with the company Milvue, the first integration of a solution within its Hub dedicated to artificial intelligence. The AI Hub enables the simple and ergonomic integration of artificial intelligence algorithms and their orchestration within clinical applications to better meet the
needs of users.

See the press release

Availability of the 2021 annual financial report

20 April 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software
solutions and designer of Myrian®, announces today the publication of its Annual
Financial Report for the year ended December 31, 2021. This Annual Financial
Report was approved by the Board of Directors on April 19, 2022.

See the press release

TeleDiag chooses Intrasense by signing a commercial contract for teleradiology

5 April 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and designer of Myrian®, and TeleDiag, a leading player in teleradiology in France entered into a partnership for the deployment of the Myrian® platform to strengthen clinical efficiency and the management of cancer patients.

See the press release

Intrasense 2021 results: record business growth

10 March 2022

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and designer of Myrian®, is today publishing audited 2021 consolidated IFRS financial statements for the Group.

See the press release

Intrasense and Forcomed sign a five-year strategic partnership agreement

1 February 2022

Intrasense and Forcomed, a leading provider of continuing medical education, have entered into a five-year partnership to enable radiologists and radiology technicians to use Myrian® during a new training module on breast imagin.

See the press release
1 4 5 6 7 8 22

Our
conferences

WebinarsPodcasts

Our
articles

Do you want to receive our news in real time?

Subscribe